Cargando…

Impact of Combined Chronic Obstructive Pulmonary Disease Status and Systemic Inflammation on Outcome of Advanced NSCLC: Multicenter Retrospective Cohort Study

BACKGROUND: In patients with non-small cell lung cancer (NSCLC), both chronic obstructive pulmonary disease (COPD) and systemic inflammatory biomarkers, such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR), have significant association with prognosis. NLR and PLR also predic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lim, Jeong Uk, Kang, Hye Seon, Yeo, Chang Dong, Kim, Ju Sang, Park, Chan Kwon, Kim, Yong Hyun, Kim, Jin Woo, Kim, Seung Joon, Lee, Sang Haak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7753914/ https://www.ncbi.nlm.nih.gov/pubmed/33363365 http://dx.doi.org/10.2147/COPD.S274354

Ejemplares similares

Regional emphysema score is associated with tumor location and poor prognosis in completely resected NSCLC patients
por: Heo, Jung Won, et al.
Publicado: (2020)

Prognostic value of platelet count and lymphocyte to monocyte ratio combination in stage IV non-small cell lung cancer with malignant pleural effusion
por: Lim, Jeong Uk, et al.
Publicado: (2018)

Elevated pretreatment platelet-to-lymphocyte ratio is associated with poor survival in stage IV non-small cell lung cancer with malignant pleural effusion
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Predictability of early changes in derived neutrophil-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2019)

Predictive Role of Prior Radiotherapy and Immunotherapy-Related Adverse Effects in Advanced NSCLC Patients Receiving Anti-PD-1/L1 Therapy
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Characteristics and clinical outcomes of patients with nonsmoking small cell lung cancer in Korea
por: Kang, Hye Seon, et al.
Publicado: (2022)

Association between clinical outcomes and local treatment in stage IV non‐small cell lung cancer patients with single extrathoracic metastasis
por: Lim, Jeong Uk, et al.
Publicado: (2022)

The association between clinical parameters and resectability in stage III non-small cell lung cancer, and a combination of N2 lymph node burden and lung immune prognostic index score as a potential biomarker
por: Kim, Seohyun, et al.
Publicado: (2023)

Chronic Obstructive Pulmonary Disease-Related Non-Small-Cell Lung Cancer Exhibits a Low Prevalence of EGFR and ALK Driver Mutations
por: Lim, Jeong Uk, et al.
Publicado: (2015)

Investigation of poor predictive factors in extensive stage small cell lung cancer under etoposide‐platinum‐atezolizumab treatment
por: Lim, Jeong Uk, et al.
Publicado: (2022)

Overall survival of driver mutation-negative non-small cell lung cancer patients with COPD under chemotherapy compared to non-COPD non-small cell lung cancer patients
por: Lim, Jeong Uk, et al.
Publicado: (2018)

Clinical significance of anemia as a prognostic factor in non-small cell lung cancer carcinoma with activating epidermal growth factor receptor mutations
por: Kang, Hye Seon, et al.
Publicado: (2020)

Smoking is associated with pneumonia development in lung cancer patients
por: Heo, Jung Won, et al.
Publicado: (2020)

Impact of smoking amount on clinicopathological features and survival in non-small cell lung cancer
por: Ban, Woo Ho, et al.
Publicado: (2020)

The Value of Residual Volume/Total Lung Capacity as an Indicator for Predicting Postoperative Lung Function in Non-Small Lung Cancer
por: Kwon, Oh-Beom, et al.
Publicado: (2021)

Identification of predictive factors for early relapse in patients with unresectable stage III non‐small cell lung cancer receiving consolidation durvalumab after concurrent chemoradiation therapy
por: Nam, Jung Hyun, et al.
Publicado: (2023)

Prediction of Postoperative Lung Function in Lung Cancer Patients Using Machine Learning Models
por: Kwon, Oh Beom, et al.
Publicado: (2023)

Chronic nicotine exposure affects programmed death-ligand 1 expression and sensitivity to epidermal growth factor receptor-tyrosine kinase inhibitor in lung cancer
por: Yeo, Chang Dong, et al.
Publicado: (2019)

Clinical characteristics and survival of patients concurrently diagnosed with lung cancer and active pulmonary tuberculosis
por: Lee, Hwa Young, et al.
Publicado: (2022)

Prevalence and analysis of tobacco use disorder in patients diagnosed with lung cancer
por: Paik, Soo-Hyun, et al.
Publicado: (2019)

Cancer organoid-based diagnosis reactivity prediction (CODRP) index-based anticancer drug sensitivity test in ALK-rearrangement positive non-small cell lung cancer (NSCLC)
por: Lee, Sang-Yun, et al.
Publicado: (2023)

Estimation of an Image Biomarker for Distant Recurrence Prediction in NSCLC Using Proliferation-Related Genes
por: Ju, Hye Min, et al.
Publicado: (2023)

Clinical significance of microbial colonization identified by initial bronchoscopy in patients with lung cancer requiring chemotherapy
por: Kang, Ji Young, et al.
Publicado: (2021)

Obstructive Fibrinous Tracheal Pseudomembrane After Tracheal Intubation: A Case Report
por: Kang, Hyeon Hui, et al.
Publicado: (2010)

Update on adjuvant therapy in completely resected NSCLC patients
por: Lim, Jeong Uk, et al.
Publicado: (2021)

Factors associated with discrepancy between fresh frozen and permanent biopsy from medical thoracoscopy: single center analysis of 172 medical flexible thoracoscopy cases
por: Lim, Jeong Uk, et al.
Publicado: (2020)

Comparison of different regimens with or without fluoroquinolone in isoniazid-resistant tuberculosis: A multicenter cohort study
por: Min, Jinsoo, et al.
Publicado: (2022)

Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Intermittent hypoxia exacerbates tumor progression in a mouse model of lung cancer
por: Kang, Hye Seon, et al.
Publicado: (2020)

Clinical significance of nuclear factor erythroid 2-related factor 2 in patients with chronic obstructive pulmonary disease
por: Ban, Woo Ho, et al.
Publicado: (2018)

Age-stratified anti-tuberculosis drug resistance profiles in South Korea: a multicenter retrospective study
por: Lee, Eung Gu, et al.
Publicado: (2020)

The relationship between sleep disturbance and health status in patients with COPD
por: Ban, Woo Ho, et al.
Publicado: (2018)

Decline in Carbon Monoxide Transfer Coefficient in Chronic Obstructive Pulmonary Disease
por: Kim, Yeon Wook, et al.
Publicado: (2020)

Pleural Fluid Pentraxin-3 for the Differential Diagnosis of Pleural Effusions
por: Yeo, Chang Dong, et al.
Publicado: (2013)

Standardization of D2 lymphadenectomy and surgical quality control (KLASS-02-QC): a prospective, observational, multicenter study [NCT01283893]
por: Kim, Hyoung-Il, et al.
Publicado: (2014)

Differences in airway inflammation according to atopic status in patients with chronic rhinitis
por: Kwon, Jae-Woo, et al.
Publicado: (2012)

Efficacy and Safety of Pembrolizumab for Gemcitabine/Cisplatin-Refractory Biliary Tract Cancer: A Multicenter Retrospective Study
por: Lee, Sang Hoon, et al.
Publicado: (2020)

Determinants of Nicotine Dependence in Chronic Obstructive Pulmonary Disease
por: Sim, Yun Su, et al.
Publicado: (2017)

Diaphragm Ultrasound is an Imaging Biomarker that Distinguishes Exacerbation Status from Stable Chronic Obstructive Pulmonary Disease
por: An, Tai Joon, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_on6qtj1r92tc7po07hpnt02uuc